케어랩스
Financials
Valuation Metrics
케어랩스's Market Cap is ₩385B. At end of 2025 it was ₩571B. Ranked #1924 of 2,421 in KR market (top 79%), #1202 of 1,640 on KOSDAQ (top 73%), #82 of 96 in Health Care Equipment & Services (top 85%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 38.46B KRW | KR#1,924/2,421 Sec#82/96 |
| Revenue | 74.01B KRW | KR#1,591/2,421 Sec#45/96 |
| Net Income | -6.66B KRW | KR—/2,421 Sec—/96 |
| Total Assets | 107.43B KRW | KR#1,725/2,421 Sec#53/96 |
| Net Assets | 74.63B KRW | KR#1,633/2,421 Sec#49/96 |
| Employees | 120 | KR#1,506/2,421 Sec#52/96 |
| Value | ||
| P/B | 0.52x | KR#831/2,421 Sec#11/96 |
| P/S | 0.52x | KR#948/2,421 Sec#10/96 |
| FCF Yield | -39.47% | KR—/2,421 Sec—/96 |
| Profitability | ||
| ROE | -8.93% | KR#1,917/2,421 Sec#65/96 |
| ROA | -6.20% | KR#1,983/2,421 Sec#68/96 |
| Op. Margin | -8.57% | KR#1,958/2,421 Sec#61/96 |
| Revenue Growth | -14.97% | KR#2,035/2,421 Sec#84/96 |
| Earnings Growth | -153.48% | KR#1,208/2,421 Sec#41/96 |
| Financial Health | ||
| Debt Ratio | 43.95% | KR#868/2,421 Sec#47/96 |
| Total Debt | 0 KRW | KR—/2,421 Sec—/96 |
| FCF | -15.18B KRW | KR#1,823/2,421 Sec#70/96 |
| Cash | 39.76B KRW | KR#856/2,421 Sec#19/96 |
| Current Ratio | 1.66x | KR#1,068/2,421 Sec#62/96 |
| Dividend | ||
| Div. Yield | 3.95% | KR#425/2,421 Sec#3/96 |
| Div. Growth | 4.92% | KR#658/2,421 Sec#22/96 |
| Performance | ||
| 1Y Return | -65.84% | KR#2,270/2,421 Sec#89/96 |
| 1M Return | 4.76% | KR#768/2,421 Sec#18/96 |
| From 52W High | -68.56% | KR#2,156/2,421 Sec#78/96 |
| 1Y MDD | -74.07% | KR#2,147/2,421 Sec#80/96 |
| Trading | ||
| Volume | 14,728 shares | KR#1,747/2,421 Sec#70/96 |
| Trading Value | 29.8M KRW | KR#2,033/2,421 Sec#82/96 |
| Foreign Own. | 2.71% | KR#1,379/2,421 Sec#48/96 |
| Per Share | ||
| EPS | -343 KRW | KR—/2,421 Sec—/96 |
| BPS | 3,844 KRW | KR#1,699/2,421 Sec#44/96 |
Company Info
CARE LABS, established in 2012 and listed on KOSDAQ in 2018, owns EDB, Goodoc, and Babitalk. The company generates synergy through its marketing and CRM businesses for medical institutions, primarily centered on mobile healthcare and beauty care platforms. As of the end of the half-year, its revenue breakdown is 42.69% from platforms, 38.07% from marketing, and 19.24% from solutions. CARE LABS is expanding its platform business in response to the growth of digital healthcare and increasing public interest in personal health management, and is headquartered in Gangnam-gu, Seoul Metropolitan City.